Actionnariat et activité des initiés pour Lexaria Bioscience Corp. (LEXX): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $3.10 |
| Capitalisation | $5M |
| Bourse | NASDAQ |
| Pays | CA |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-03-17 | BUNKA CHRISTOPHER | G-Gift | 100,000 | |
| 2025-07-30 | BUNKA CHRISTOPHER | P-Purchase | 11,900 | $11K |
| 2025-07-29 | BUNKA CHRISTOPHER | P-Purchase | 15,600 | $14K |
| 2025-07-29 | McKechnie William Edward | P-Purchase | 5,000 | $5K |
| 2025-07-29 | DOCHERTY JOHN MARTIN | P-Purchase | 5,376 | $5K |
| 2025-07-29 | Carle Vanessa | P-Purchase | 750 | $682 |
| 2025-07-29 | CHRISTOPHER RICHARD | P-Purchase | 15,000 | $14K |
| 2025-05-15 | CHRISTOPHER RICHARD | A-Award | 150,000 | $156K |
| 2025-05-15 | BUNKA CHRISTOPHER | A-Award | 11,000 | $11K |
| 2025-05-15 | Carle Vanessa | A-Award | 15,000 | $16K |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $93409 | $2.5M | $1.7M | $1.3M | $1.3M | $10.9M | $5.8M | $1.4M | $6.5M | $1.8M |
| Placements à Court Terme | 0 | 0 | $10151 | $64214 | $19321 | $833841 | $347335 | $125642 | $55807 | $165360 |
| Créances | $131083 | $45293 | $265751 | $273145 | $313925 | $342401 | $201784 | $175245 | $154477 | $174000 |
| Stocks | $134724 | $67174 | $87233 | $127396 | $116871 | $29648 | $38418 | 0 | 0 | 0 |
| Actifs Courants | $510166 | $2.8M | $2.3M | $1.8M | $1.9M | $12.4M | $7.0M | $2.2M | $7.9M | $3.5M |
| Immobilisations Corporelles | $2475 | $1856 | $1237 | $591263 | $610277 | $459254 | $367949 | $421589 | $389552 | $334945 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | $53997 | $62827 | $146538 | $265127 | $292000 | $364623 | $488462 | $462625 | $516676 | $307818 |
| Actifs Totaux | $566638 | $2.9M | $2.4M | $2.7M | $2.8M | $13.3M | $7.8M | $3.1M | $8.9M | $4.2M |
| Dettes Fournisseurs | $90010 | $32574 | $14378 | $31463 | $45080 | $104891 | $120146 | $225038 | $1.1M | $1.4M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | $7926 | 0 | 0 | 0 | 0 |
| Passifs Courants | $433881 | $92347 | $43640 | $184507 | $225917 | $153276 | $194036 | $267735 | $1.1M | $1.5M |
| Dette à Long Terme | $45000 | 0 | 0 | 0 | $30670 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $478881 | $92347 | $43640 | $184507 | $345980 | $203265 | $201437 | $403908 | $1.2M | $1.6M |
| Réserves | -$11.3M | -$13.2M | -$19.8M | -$23.9M | -$27.8M | -$31.8M | -$39.1M | -$45.8M | -$51.6M | -$63.5M |
| Capitaux Propres | $266045 | $3.0M | $2.4M | $2.4M | $2.5M | $13.3M | $7.9M | $3.0M | $8.0M | $3.0M |
| Dette Totale | $45000 | $42690 | $7855 | 0 | $156101 | $97319 | $49988 | $163967 | $137366 | $109320 |
| Dette Nette | -$48409 | -$2.5M | -$1.7M | -$1.3M | -$1.2M | -$11.7M | -$6.1M | -$1.3M | -$6.4M | -$1.9M |
| Fonds de Roulement | $76285 | $2.7M | $2.2M | $1.6M | $1.7M | $12.3M | $6.8M | $1.9M | $6.8M | $2.0M |
Santé financière
| Dette / Capitaux propres | 0.02 |
| Ratio de liquidité | 10.60 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -23.89 |
Rentabilité
| Rentabilité des capitaux propres | -160.72% |
| Rentabilité du capital investi | -173.96% |
| Rentabilité des actifs | -161.71% |
| Marge brute | 100.00% |
| Marge opérationnelle | -3973.16% |
| Marge nette | -3985.58% |
Entreprises liées: ALLR · BCTX · CASI · CING · CLSD · CRIS · ENTO
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de LEXX: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions